SCHEMBL25826719

SCHEMBL25826719

CC(C)Oc1ccnc2ccc(N(C)C)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DOT1L Q8TEK3 1/20 0.48
IP6K1 Q92551 1/20 0.43
IRAK4 Q9NWZ3 13/20 0.42
EGFR P00533 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPK1 P28482 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
TERT O14746 1/20 0.36
APP P05067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24010781 0.84 DOT1L (0.63) DOT1LIP6K1EGFRALDH1A1HSD17B10
SCHEMBL24003975 0.81 DOT1L (0.50) DOT1LIP6K1EGFRMEN1ALDH1A1
SCHEMBL2621791 0.78 GAK (0.46) IRAK4EGFRLMNAACVR1
SCHEMBL13409355 0.78 IDO1 (0.50) IRAK4
SCHEMBL25826712 0.78 PDE3B (0.44) DOT1LIP6K1EGFRALDH1A1MAPK1
SCHEMBL12282776 0.74 MAPT (0.47) IRAK4MEN1KMT2AACVR1
SCHEMBL12240676 0.74 IP6K1 (0.50) DOT1LIP6K1EGFRMEN1ALDH1A1
SCHEMBL25820108 0.73 IP6K1 (0.43) DOT1LIP6K1EGFRMEN1ALDH1A1
SCHEMBL25835191 0.72 IRAK4 (0.40) IRAK4
SCHEMBL1862289 0.72 DOT1L (0.50) DOT1LIP6K1EGFRMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR DOT1L 4010/4885IP6K1 186/4885IRAK4 1748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.